A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.

FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...

Per Moderna, mNexspike offers improved shelf life and storage benefits — key advantages for broad U.S. distribution, especially in areas with limited cold-chain infrastructure. The FDA approval ...

Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

This is the same limited use the FDA set in licensing the Novavax COVID-19 vaccine last month. This fall, Moderna anticipates offering both Spikevax and mNexspike as COVID-19 vaccines.